Smith Group Asset Management »

Corcept Therapeutics Incorporated shares owned by Smith Group Asset Management

Quarter-by-quarter ownership of Corcept Therapeutics Incorporated (CORT) shares owned by Smith Group Asset Management from 13F filings

Historical chart of Smith Group Asset Management investment in Corcept Therapeutics Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Corcept Therapeutics Incorporated held by Smith Group Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Corcept Therapeutics Incorporated by Smith Group Asset Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $776k 15k 50.39
2024-09-30 $706k 15k 46.28
2024-06-30 $396k 12k 32.49
2024-03-31 $305k 12k 25.19
2023-12-31 $393k 12k 32.48
2021-09-30 $540k 27k 19.69

More positions owned by Smith Group Asset Management

Apple (AAPL)
Microsoft Corporation (MSFT)
Applovin Corp Com Cl A (APP)
Costco Wholesale Corporation (COST)
Booking Holdings (BKNG)
Meta Platforms Cl A (META)
Parker-Hannifin Corporation (PH)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Ameriprise Financial (AMP)
American Express Company (AXP)
Arista Networks Com Shs
Kla Corp Com New (KLAC)
Cadence Design Systems (CDNS)
Netflix (NFLX)

View all positions for Smith Group Asset Management

Top funds holding Corcept Therapeutics Incorporated

BlackRock
Vanguard Group
Ingalls & Snyder
Renaissance Technologies
Parallel Advisors
State Street Corporation
Dimensional Fund Advisors
Novo A/S
Geode Capital Management
Arrowstreet Capital, Limited Partnership
FMR
First Trust Advisors
Jacobs Levy Equity Management
Charles Schwab Investment Management
Northern Trust

View all funds holding Corcept Therapeutics Incorporated